nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Paraesthesia—Capecitabine—stomach cancer	0.000181	0.000221	CcSEcCtD
Escitalopram—Decreased appetite—Docetaxel—stomach cancer	0.000181	0.000221	CcSEcCtD
Escitalopram—Headache—Fluorouracil—stomach cancer	0.000181	0.00022	CcSEcCtD
Escitalopram—Urinary tract disorder—Doxorubicin—stomach cancer	0.000181	0.00022	CcSEcCtD
Escitalopram—Oedema peripheral—Doxorubicin—stomach cancer	0.00018	0.00022	CcSEcCtD
Escitalopram—Dysgeusia—Methotrexate—stomach cancer	0.00018	0.00022	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00018	0.000219	CcSEcCtD
Escitalopram—Connective tissue disorder—Doxorubicin—stomach cancer	0.00018	0.000219	CcSEcCtD
Escitalopram—Dyspnoea—Capecitabine—stomach cancer	0.00018	0.000219	CcSEcCtD
Escitalopram—Fatigue—Docetaxel—stomach cancer	0.000179	0.000219	CcSEcCtD
Escitalopram—Angiopathy—Epirubicin—stomach cancer	0.000179	0.000219	CcSEcCtD
Escitalopram—Urethral disorder—Doxorubicin—stomach cancer	0.000179	0.000219	CcSEcCtD
Escitalopram—Nausea—Irinotecan—stomach cancer	0.000179	0.000218	CcSEcCtD
Escitalopram—Immune system disorder—Epirubicin—stomach cancer	0.000179	0.000218	CcSEcCtD
Escitalopram—Mediastinal disorder—Epirubicin—stomach cancer	0.000178	0.000217	CcSEcCtD
Escitalopram—Pain—Docetaxel—stomach cancer	0.000178	0.000217	CcSEcCtD
Escitalopram—Constipation—Docetaxel—stomach cancer	0.000178	0.000217	CcSEcCtD
Escitalopram—Back pain—Methotrexate—stomach cancer	0.000178	0.000217	CcSEcCtD
Escitalopram—Dyspepsia—Capecitabine—stomach cancer	0.000177	0.000216	CcSEcCtD
Escitalopram—Chills—Epirubicin—stomach cancer	0.000177	0.000216	CcSEcCtD
Escitalopram—Arrhythmia—Epirubicin—stomach cancer	0.000177	0.000215	CcSEcCtD
Escitalopram—Visual impairment—Doxorubicin—stomach cancer	0.000176	0.000215	CcSEcCtD
Escitalopram—Decreased appetite—Capecitabine—stomach cancer	0.000175	0.000214	CcSEcCtD
Escitalopram—Alopecia—Epirubicin—stomach cancer	0.000175	0.000213	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000174	0.000212	CcSEcCtD
Escitalopram—Fatigue—Capecitabine—stomach cancer	0.000174	0.000212	CcSEcCtD
Escitalopram—Vision blurred—Methotrexate—stomach cancer	0.000173	0.000211	CcSEcCtD
Escitalopram—Mental disorder—Epirubicin—stomach cancer	0.000173	0.000211	CcSEcCtD
Escitalopram—Erythema multiforme—Doxorubicin—stomach cancer	0.000173	0.000211	CcSEcCtD
Escitalopram—Pain—Capecitabine—stomach cancer	0.000172	0.00021	CcSEcCtD
Escitalopram—Constipation—Capecitabine—stomach cancer	0.000172	0.00021	CcSEcCtD
Escitalopram—Malnutrition—Epirubicin—stomach cancer	0.000172	0.00021	CcSEcCtD
Escitalopram—Erythema—Epirubicin—stomach cancer	0.000172	0.00021	CcSEcCtD
Escitalopram—Feeling abnormal—Docetaxel—stomach cancer	0.000172	0.000209	CcSEcCtD
Escitalopram—Nausea—Fluorouracil—stomach cancer	0.000171	0.000209	CcSEcCtD
Escitalopram—Eye disorder—Doxorubicin—stomach cancer	0.000171	0.000208	CcSEcCtD
Escitalopram—Ill-defined disorder—Methotrexate—stomach cancer	0.000171	0.000208	CcSEcCtD
Escitalopram—Tinnitus—Doxorubicin—stomach cancer	0.000171	0.000208	CcSEcCtD
Escitalopram—Gastrointestinal pain—Docetaxel—stomach cancer	0.00017	0.000208	CcSEcCtD
Escitalopram—Anaemia—Methotrexate—stomach cancer	0.00017	0.000207	CcSEcCtD
Escitalopram—Cardiac disorder—Doxorubicin—stomach cancer	0.00017	0.000207	CcSEcCtD
Escitalopram—Flushing—Doxorubicin—stomach cancer	0.00017	0.000207	CcSEcCtD
Escitalopram—Flatulence—Epirubicin—stomach cancer	0.00017	0.000207	CcSEcCtD
Escitalopram—Tension—Epirubicin—stomach cancer	0.000169	0.000206	CcSEcCtD
Escitalopram—Dysgeusia—Epirubicin—stomach cancer	0.000168	0.000205	CcSEcCtD
Escitalopram—Nervousness—Epirubicin—stomach cancer	0.000167	0.000204	CcSEcCtD
Escitalopram—Back pain—Epirubicin—stomach cancer	0.000166	0.000203	CcSEcCtD
Escitalopram—Feeling abnormal—Capecitabine—stomach cancer	0.000166	0.000203	CcSEcCtD
Escitalopram—Angiopathy—Doxorubicin—stomach cancer	0.000166	0.000202	CcSEcCtD
Escitalopram—Malaise—Methotrexate—stomach cancer	0.000166	0.000202	CcSEcCtD
Escitalopram—Muscle spasms—Epirubicin—stomach cancer	0.000165	0.000202	CcSEcCtD
Escitalopram—Immune system disorder—Doxorubicin—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Vertigo—Methotrexate—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Gastrointestinal pain—Capecitabine—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Mediastinal disorder—Doxorubicin—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Abdominal pain—Docetaxel—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Body temperature increased—Docetaxel—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Leukopenia—Methotrexate—stomach cancer	0.000165	0.000201	CcSEcCtD
Escitalopram—Chills—Doxorubicin—stomach cancer	0.000164	0.0002	CcSEcCtD
Escitalopram—Arrhythmia—Doxorubicin—stomach cancer	0.000163	0.000199	CcSEcCtD
Escitalopram—Vision blurred—Epirubicin—stomach cancer	0.000162	0.000198	CcSEcCtD
Escitalopram—Alopecia—Doxorubicin—stomach cancer	0.000162	0.000197	CcSEcCtD
Escitalopram—Cough—Methotrexate—stomach cancer	0.00016	0.000196	CcSEcCtD
Escitalopram—Mental disorder—Doxorubicin—stomach cancer	0.00016	0.000195	CcSEcCtD
Escitalopram—Urticaria—Capecitabine—stomach cancer	0.00016	0.000195	CcSEcCtD
Escitalopram—Ill-defined disorder—Epirubicin—stomach cancer	0.00016	0.000195	CcSEcCtD
Escitalopram—Abdominal pain—Capecitabine—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Body temperature increased—Capecitabine—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Convulsion—Methotrexate—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Erythema—Doxorubicin—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Malnutrition—Doxorubicin—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Anaemia—Epirubicin—stomach cancer	0.000159	0.000194	CcSEcCtD
Escitalopram—Agitation—Epirubicin—stomach cancer	0.000158	0.000193	CcSEcCtD
Escitalopram—Flatulence—Doxorubicin—stomach cancer	0.000157	0.000191	CcSEcCtD
Escitalopram—Chest pain—Methotrexate—stomach cancer	0.000157	0.000191	CcSEcCtD
Escitalopram—Myalgia—Methotrexate—stomach cancer	0.000157	0.000191	CcSEcCtD
Escitalopram—Arthralgia—Methotrexate—stomach cancer	0.000157	0.000191	CcSEcCtD
Escitalopram—Tension—Doxorubicin—stomach cancer	0.000156	0.000191	CcSEcCtD
Escitalopram—Dysgeusia—Doxorubicin—stomach cancer	0.000156	0.00019	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000155	0.00019	CcSEcCtD
Escitalopram—Malaise—Epirubicin—stomach cancer	0.000155	0.000189	CcSEcCtD
Escitalopram—Discomfort—Methotrexate—stomach cancer	0.000155	0.000189	CcSEcCtD
Escitalopram—Nervousness—Doxorubicin—stomach cancer	0.000155	0.000189	CcSEcCtD
Escitalopram—Vertigo—Epirubicin—stomach cancer	0.000155	0.000189	CcSEcCtD
Escitalopram—Syncope—Epirubicin—stomach cancer	0.000154	0.000188	CcSEcCtD
Escitalopram—Leukopenia—Epirubicin—stomach cancer	0.000154	0.000188	CcSEcCtD
Escitalopram—Back pain—Doxorubicin—stomach cancer	0.000154	0.000188	CcSEcCtD
Escitalopram—Hypersensitivity—Docetaxel—stomach cancer	0.000153	0.000187	CcSEcCtD
Escitalopram—Muscle spasms—Doxorubicin—stomach cancer	0.000153	0.000187	CcSEcCtD
Escitalopram—Palpitations—Epirubicin—stomach cancer	0.000152	0.000185	CcSEcCtD
Escitalopram—Confusional state—Methotrexate—stomach cancer	0.000151	0.000185	CcSEcCtD
Escitalopram—Loss of consciousness—Epirubicin—stomach cancer	0.000151	0.000184	CcSEcCtD
Escitalopram—Cough—Epirubicin—stomach cancer	0.00015	0.000183	CcSEcCtD
Escitalopram—Anaphylactic shock—Methotrexate—stomach cancer	0.00015	0.000183	CcSEcCtD
Escitalopram—Vision blurred—Doxorubicin—stomach cancer	0.00015	0.000183	CcSEcCtD
Escitalopram—Asthenia—Docetaxel—stomach cancer	0.000149	0.000182	CcSEcCtD
Escitalopram—Convulsion—Epirubicin—stomach cancer	0.000149	0.000182	CcSEcCtD
Escitalopram—Infection—Methotrexate—stomach cancer	0.000149	0.000182	CcSEcCtD
Escitalopram—Hypertension—Epirubicin—stomach cancer	0.000149	0.000181	CcSEcCtD
Escitalopram—Hypersensitivity—Capecitabine—stomach cancer	0.000148	0.000181	CcSEcCtD
Escitalopram—Ill-defined disorder—Doxorubicin—stomach cancer	0.000148	0.00018	CcSEcCtD
Escitalopram—Pruritus—Docetaxel—stomach cancer	0.000147	0.00018	CcSEcCtD
Escitalopram—Nervous system disorder—Methotrexate—stomach cancer	0.000147	0.000179	CcSEcCtD
Escitalopram—Anaemia—Doxorubicin—stomach cancer	0.000147	0.000179	CcSEcCtD
Escitalopram—Thrombocytopenia—Methotrexate—stomach cancer	0.000147	0.000179	CcSEcCtD
Escitalopram—Chest pain—Epirubicin—stomach cancer	0.000146	0.000179	CcSEcCtD
Escitalopram—Myalgia—Epirubicin—stomach cancer	0.000146	0.000179	CcSEcCtD
Escitalopram—Arthralgia—Epirubicin—stomach cancer	0.000146	0.000179	CcSEcCtD
Escitalopram—Agitation—Doxorubicin—stomach cancer	0.000146	0.000178	CcSEcCtD
Escitalopram—Anxiety—Epirubicin—stomach cancer	0.000146	0.000178	CcSEcCtD
Escitalopram—Skin disorder—Methotrexate—stomach cancer	0.000146	0.000178	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000145	0.000177	CcSEcCtD
Escitalopram—Hyperhidrosis—Methotrexate—stomach cancer	0.000145	0.000177	CcSEcCtD
Escitalopram—Discomfort—Epirubicin—stomach cancer	0.000145	0.000177	CcSEcCtD
Escitalopram—Asthenia—Capecitabine—stomach cancer	0.000145	0.000176	CcSEcCtD
Escitalopram—Malaise—Doxorubicin—stomach cancer	0.000144	0.000175	CcSEcCtD
Escitalopram—Dry mouth—Epirubicin—stomach cancer	0.000143	0.000175	CcSEcCtD
Escitalopram—Vertigo—Doxorubicin—stomach cancer	0.000143	0.000174	CcSEcCtD
Escitalopram—Anorexia—Methotrexate—stomach cancer	0.000143	0.000174	CcSEcCtD
Escitalopram—Syncope—Doxorubicin—stomach cancer	0.000143	0.000174	CcSEcCtD
Escitalopram—Pruritus—Capecitabine—stomach cancer	0.000143	0.000174	CcSEcCtD
Escitalopram—Leukopenia—Doxorubicin—stomach cancer	0.000142	0.000174	CcSEcCtD
Escitalopram—Diarrhoea—Docetaxel—stomach cancer	0.000142	0.000174	CcSEcCtD
Escitalopram—Confusional state—Epirubicin—stomach cancer	0.000142	0.000173	CcSEcCtD
Escitalopram—Palpitations—Doxorubicin—stomach cancer	0.000141	0.000172	CcSEcCtD
Escitalopram—Anaphylactic shock—Epirubicin—stomach cancer	0.00014	0.000171	CcSEcCtD
Escitalopram—Oedema—Epirubicin—stomach cancer	0.00014	0.000171	CcSEcCtD
Escitalopram—Hypotension—Methotrexate—stomach cancer	0.00014	0.000171	CcSEcCtD
Escitalopram—Loss of consciousness—Doxorubicin—stomach cancer	0.00014	0.000171	CcSEcCtD
Escitalopram—Infection—Epirubicin—stomach cancer	0.000139	0.00017	CcSEcCtD
Escitalopram—Cough—Doxorubicin—stomach cancer	0.000139	0.000169	CcSEcCtD
Escitalopram—Shock—Epirubicin—stomach cancer	0.000138	0.000168	CcSEcCtD
Escitalopram—Convulsion—Doxorubicin—stomach cancer	0.000138	0.000168	CcSEcCtD
Escitalopram—Diarrhoea—Capecitabine—stomach cancer	0.000138	0.000168	CcSEcCtD
Escitalopram—Nervous system disorder—Epirubicin—stomach cancer	0.000138	0.000168	CcSEcCtD
Escitalopram—Dizziness—Docetaxel—stomach cancer	0.000138	0.000168	CcSEcCtD
Escitalopram—Thrombocytopenia—Epirubicin—stomach cancer	0.000137	0.000168	CcSEcCtD
Escitalopram—Hypertension—Doxorubicin—stomach cancer	0.000137	0.000168	CcSEcCtD
Escitalopram—Tachycardia—Epirubicin—stomach cancer	0.000137	0.000167	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000137	0.000167	CcSEcCtD
Escitalopram—Skin disorder—Epirubicin—stomach cancer	0.000136	0.000166	CcSEcCtD
Escitalopram—Hyperhidrosis—Epirubicin—stomach cancer	0.000136	0.000166	CcSEcCtD
Escitalopram—Insomnia—Methotrexate—stomach cancer	0.000136	0.000166	CcSEcCtD
Escitalopram—Chest pain—Doxorubicin—stomach cancer	0.000136	0.000165	CcSEcCtD
Escitalopram—Myalgia—Doxorubicin—stomach cancer	0.000136	0.000165	CcSEcCtD
Escitalopram—Arthralgia—Doxorubicin—stomach cancer	0.000136	0.000165	CcSEcCtD
Escitalopram—Anxiety—Doxorubicin—stomach cancer	0.000135	0.000165	CcSEcCtD
Escitalopram—Paraesthesia—Methotrexate—stomach cancer	0.000135	0.000164	CcSEcCtD
Escitalopram—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000135	0.000164	CcSEcCtD
Escitalopram—Discomfort—Doxorubicin—stomach cancer	0.000134	0.000163	CcSEcCtD
Escitalopram—Anorexia—Epirubicin—stomach cancer	0.000134	0.000163	CcSEcCtD
Escitalopram—Dyspnoea—Methotrexate—stomach cancer	0.000134	0.000163	CcSEcCtD
Escitalopram—Somnolence—Methotrexate—stomach cancer	0.000133	0.000163	CcSEcCtD
Escitalopram—Dizziness—Capecitabine—stomach cancer	0.000133	0.000163	CcSEcCtD
Escitalopram—Dry mouth—Doxorubicin—stomach cancer	0.000133	0.000162	CcSEcCtD
Escitalopram—Vomiting—Docetaxel—stomach cancer	0.000132	0.000161	CcSEcCtD
Escitalopram—Dyspepsia—Methotrexate—stomach cancer	0.000132	0.000161	CcSEcCtD
Escitalopram—Rash—Docetaxel—stomach cancer	0.000131	0.00016	CcSEcCtD
Escitalopram—Hypotension—Epirubicin—stomach cancer	0.000131	0.00016	CcSEcCtD
Escitalopram—Dermatitis—Docetaxel—stomach cancer	0.000131	0.00016	CcSEcCtD
Escitalopram—Confusional state—Doxorubicin—stomach cancer	0.000131	0.00016	CcSEcCtD
Escitalopram—Decreased appetite—Methotrexate—stomach cancer	0.00013	0.000159	CcSEcCtD
Escitalopram—Headache—Docetaxel—stomach cancer	0.00013	0.000159	CcSEcCtD
Escitalopram—Anaphylactic shock—Doxorubicin—stomach cancer	0.00013	0.000158	CcSEcCtD
Escitalopram—Oedema—Doxorubicin—stomach cancer	0.00013	0.000158	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00013	0.000158	CcSEcCtD
Escitalopram—Fatigue—Methotrexate—stomach cancer	0.000129	0.000158	CcSEcCtD
Escitalopram—Infection—Doxorubicin—stomach cancer	0.000129	0.000157	CcSEcCtD
Escitalopram—Pain—Methotrexate—stomach cancer	0.000128	0.000156	CcSEcCtD
Escitalopram—Vomiting—Capecitabine—stomach cancer	0.000128	0.000156	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000128	0.000156	CcSEcCtD
Escitalopram—Shock—Doxorubicin—stomach cancer	0.000128	0.000156	CcSEcCtD
Escitalopram—Nervous system disorder—Doxorubicin—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Thrombocytopenia—Doxorubicin—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Rash—Capecitabine—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Insomnia—Epirubicin—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Dermatitis—Capecitabine—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Tachycardia—Doxorubicin—stomach cancer	0.000127	0.000155	CcSEcCtD
Escitalopram—Headache—Capecitabine—stomach cancer	0.000126	0.000154	CcSEcCtD
Escitalopram—Skin disorder—Doxorubicin—stomach cancer	0.000126	0.000154	CcSEcCtD
Escitalopram—Paraesthesia—Epirubicin—stomach cancer	0.000126	0.000154	CcSEcCtD
Escitalopram—Hyperhidrosis—Doxorubicin—stomach cancer	0.000126	0.000153	CcSEcCtD
Escitalopram—Dyspnoea—Epirubicin—stomach cancer	0.000125	0.000153	CcSEcCtD
Escitalopram—Somnolence—Epirubicin—stomach cancer	0.000125	0.000152	CcSEcCtD
Escitalopram—Anorexia—Doxorubicin—stomach cancer	0.000124	0.000151	CcSEcCtD
Escitalopram—Nausea—Docetaxel—stomach cancer	0.000124	0.000151	CcSEcCtD
Escitalopram—Feeling abnormal—Methotrexate—stomach cancer	0.000124	0.000151	CcSEcCtD
Escitalopram—Dyspepsia—Epirubicin—stomach cancer	0.000124	0.000151	CcSEcCtD
Escitalopram—Gastrointestinal pain—Methotrexate—stomach cancer	0.000123	0.00015	CcSEcCtD
Escitalopram—Decreased appetite—Epirubicin—stomach cancer	0.000122	0.000149	CcSEcCtD
Escitalopram—Hypotension—Doxorubicin—stomach cancer	0.000121	0.000148	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000121	0.000148	CcSEcCtD
Escitalopram—Fatigue—Epirubicin—stomach cancer	0.000121	0.000148	CcSEcCtD
Escitalopram—Pain—Epirubicin—stomach cancer	0.00012	0.000146	CcSEcCtD
Escitalopram—Constipation—Epirubicin—stomach cancer	0.00012	0.000146	CcSEcCtD
Escitalopram—Nausea—Capecitabine—stomach cancer	0.00012	0.000146	CcSEcCtD
Escitalopram—Urticaria—Methotrexate—stomach cancer	0.000119	0.000145	CcSEcCtD
Escitalopram—Abdominal pain—Methotrexate—stomach cancer	0.000119	0.000145	CcSEcCtD
Escitalopram—Body temperature increased—Methotrexate—stomach cancer	0.000119	0.000145	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000118	0.000144	CcSEcCtD
Escitalopram—Insomnia—Doxorubicin—stomach cancer	0.000118	0.000143	CcSEcCtD
Escitalopram—Paraesthesia—Doxorubicin—stomach cancer	0.000117	0.000142	CcSEcCtD
Escitalopram—Dyspnoea—Doxorubicin—stomach cancer	0.000116	0.000141	CcSEcCtD
Escitalopram—Feeling abnormal—Epirubicin—stomach cancer	0.000116	0.000141	CcSEcCtD
Escitalopram—Somnolence—Doxorubicin—stomach cancer	0.000116	0.000141	CcSEcCtD
Escitalopram—Gastrointestinal pain—Epirubicin—stomach cancer	0.000115	0.00014	CcSEcCtD
Escitalopram—Dyspepsia—Doxorubicin—stomach cancer	0.000114	0.000139	CcSEcCtD
Escitalopram—Decreased appetite—Doxorubicin—stomach cancer	0.000113	0.000138	CcSEcCtD
Escitalopram—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000112	0.000137	CcSEcCtD
Escitalopram—Fatigue—Doxorubicin—stomach cancer	0.000112	0.000137	CcSEcCtD
Escitalopram—Urticaria—Epirubicin—stomach cancer	0.000112	0.000136	CcSEcCtD
Escitalopram—Constipation—Doxorubicin—stomach cancer	0.000111	0.000136	CcSEcCtD
Escitalopram—Pain—Doxorubicin—stomach cancer	0.000111	0.000136	CcSEcCtD
Escitalopram—Body temperature increased—Epirubicin—stomach cancer	0.000111	0.000135	CcSEcCtD
Escitalopram—Abdominal pain—Epirubicin—stomach cancer	0.000111	0.000135	CcSEcCtD
Escitalopram—Hypersensitivity—Methotrexate—stomach cancer	0.000111	0.000135	CcSEcCtD
Escitalopram—Asthenia—Methotrexate—stomach cancer	0.000108	0.000131	CcSEcCtD
Escitalopram—Feeling abnormal—Doxorubicin—stomach cancer	0.000107	0.000131	CcSEcCtD
Escitalopram—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000106	0.00013	CcSEcCtD
Escitalopram—Pruritus—Methotrexate—stomach cancer	0.000106	0.000129	CcSEcCtD
Escitalopram—Hypersensitivity—Epirubicin—stomach cancer	0.000103	0.000126	CcSEcCtD
Escitalopram—Urticaria—Doxorubicin—stomach cancer	0.000103	0.000126	CcSEcCtD
Escitalopram—Abdominal pain—Doxorubicin—stomach cancer	0.000103	0.000125	CcSEcCtD
Escitalopram—Body temperature increased—Doxorubicin—stomach cancer	0.000103	0.000125	CcSEcCtD
Escitalopram—Diarrhoea—Methotrexate—stomach cancer	0.000103	0.000125	CcSEcCtD
Escitalopram—Asthenia—Epirubicin—stomach cancer	0.000101	0.000123	CcSEcCtD
Escitalopram—Pruritus—Epirubicin—stomach cancer	9.93e-05	0.000121	CcSEcCtD
Escitalopram—Dizziness—Methotrexate—stomach cancer	9.92e-05	0.000121	CcSEcCtD
Escitalopram—Diarrhoea—Epirubicin—stomach cancer	9.61e-05	0.000117	CcSEcCtD
Escitalopram—Hypersensitivity—Doxorubicin—stomach cancer	9.57e-05	0.000117	CcSEcCtD
Escitalopram—Vomiting—Methotrexate—stomach cancer	9.54e-05	0.000116	CcSEcCtD
Escitalopram—Rash—Methotrexate—stomach cancer	9.46e-05	0.000115	CcSEcCtD
Escitalopram—Dermatitis—Methotrexate—stomach cancer	9.45e-05	0.000115	CcSEcCtD
Escitalopram—Headache—Methotrexate—stomach cancer	9.4e-05	0.000115	CcSEcCtD
Escitalopram—Asthenia—Doxorubicin—stomach cancer	9.32e-05	0.000114	CcSEcCtD
Escitalopram—Dizziness—Epirubicin—stomach cancer	9.29e-05	0.000113	CcSEcCtD
Escitalopram—Pruritus—Doxorubicin—stomach cancer	9.19e-05	0.000112	CcSEcCtD
Escitalopram—Vomiting—Epirubicin—stomach cancer	8.93e-05	0.000109	CcSEcCtD
Escitalopram—Nausea—Methotrexate—stomach cancer	8.91e-05	0.000109	CcSEcCtD
Escitalopram—Diarrhoea—Doxorubicin—stomach cancer	8.89e-05	0.000108	CcSEcCtD
Escitalopram—Rash—Epirubicin—stomach cancer	8.85e-05	0.000108	CcSEcCtD
Escitalopram—Dermatitis—Epirubicin—stomach cancer	8.85e-05	0.000108	CcSEcCtD
Escitalopram—Headache—Epirubicin—stomach cancer	8.8e-05	0.000107	CcSEcCtD
Escitalopram—Dizziness—Doxorubicin—stomach cancer	8.59e-05	0.000105	CcSEcCtD
Escitalopram—Nausea—Epirubicin—stomach cancer	8.34e-05	0.000102	CcSEcCtD
Escitalopram—Vomiting—Doxorubicin—stomach cancer	8.26e-05	0.000101	CcSEcCtD
Escitalopram—Rash—Doxorubicin—stomach cancer	8.19e-05	9.99e-05	CcSEcCtD
Escitalopram—Dermatitis—Doxorubicin—stomach cancer	8.18e-05	9.98e-05	CcSEcCtD
Escitalopram—Headache—Doxorubicin—stomach cancer	8.14e-05	9.93e-05	CcSEcCtD
Escitalopram—Nausea—Doxorubicin—stomach cancer	7.72e-05	9.41e-05	CcSEcCtD
Escitalopram—HTR2C—Signaling Pathways—SMAD4—stomach cancer	2.91e-05	0.000162	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—CXCL8—stomach cancer	2.88e-05	0.00016	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6R—stomach cancer	2.86e-05	0.000159	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—AKR1C3—stomach cancer	2.85e-05	0.000158	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6R—stomach cancer	2.85e-05	0.000158	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—RHOA—stomach cancer	2.84e-05	0.000158	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—RHOA—stomach cancer	2.83e-05	0.000157	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	2.8e-05	0.000156	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	2.79e-05	0.000155	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ENO1—stomach cancer	2.78e-05	0.000154	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ADRB2—stomach cancer	2.77e-05	0.000154	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FYN—stomach cancer	2.76e-05	0.000153	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ADRB2—stomach cancer	2.76e-05	0.000153	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.73e-05	0.000152	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTT1—stomach cancer	2.73e-05	0.000152	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	2.72e-05	0.000151	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PPP2R1A—stomach cancer	2.71e-05	0.000151	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ECHS1—stomach cancer	2.71e-05	0.00015	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PDHA1—stomach cancer	2.71e-05	0.00015	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PPP2R1A—stomach cancer	2.71e-05	0.00015	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CYP2A6—stomach cancer	2.7e-05	0.00015	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	2.66e-05	0.000148	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—AKR1C3—stomach cancer	2.62e-05	0.000146	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—CXCL8—stomach cancer	2.61e-05	0.000145	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—FGFR2—stomach cancer	2.59e-05	0.000144	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—RHOA—stomach cancer	2.58e-05	0.000143	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—RHOA—stomach cancer	2.57e-05	0.000143	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ENO1—stomach cancer	2.56e-05	0.000142	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—FADS1—stomach cancer	2.54e-05	0.000141	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TYMP—stomach cancer	2.54e-05	0.000141	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	2.53e-05	0.000141	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SMAD4—stomach cancer	2.52e-05	0.00014	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SMAD4—stomach cancer	2.51e-05	0.000139	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—CXCL8—stomach cancer	2.49e-05	0.000138	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—CXCL8—stomach cancer	2.49e-05	0.000138	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	2.47e-05	0.000137	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CD44—stomach cancer	2.47e-05	0.000137	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	2.45e-05	0.000136	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FYN—stomach cancer	2.39e-05	0.000133	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	2.39e-05	0.000133	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FYN—stomach cancer	2.39e-05	0.000132	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SREBF2—stomach cancer	2.38e-05	0.000132	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IRS2—stomach cancer	2.37e-05	0.000132	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—RORA—stomach cancer	2.35e-05	0.000131	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FYN—stomach cancer	2.35e-05	0.00013	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CAV1—stomach cancer	2.3e-05	0.000128	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APOA1—stomach cancer	2.3e-05	0.000128	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CD44—stomach cancer	2.27e-05	0.000126	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—CXCL8—stomach cancer	2.26e-05	0.000126	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—CXCL8—stomach cancer	2.26e-05	0.000125	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—FGFR2—stomach cancer	2.25e-05	0.000125	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—FGFR2—stomach cancer	2.24e-05	0.000124	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	2.22e-05	0.000123	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALDOB—stomach cancer	2.21e-05	0.000123	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	2.2e-05	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRKCB—stomach cancer	2.19e-05	0.000122	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6ST—stomach cancer	2.18e-05	0.000121	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPP2R1A—stomach cancer	2.1e-05	0.000116	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—APC—stomach cancer	2.1e-05	0.000116	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IRS2—stomach cancer	2.06e-05	0.000114	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTP1—stomach cancer	2.06e-05	0.000114	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALOX5—stomach cancer	2.05e-05	0.000114	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IRS2—stomach cancer	2.05e-05	0.000114	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—HMOX1—stomach cancer	2.03e-05	0.000113	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IRS2—stomach cancer	2.02e-05	0.000112	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—DPYD—stomach cancer	2.02e-05	0.000112	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MAPK3—stomach cancer	2.01e-05	0.000111	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CAV1—stomach cancer	1.99e-05	0.000111	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APOA1—stomach cancer	1.99e-05	0.00011	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CAV1—stomach cancer	1.99e-05	0.00011	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APOA1—stomach cancer	1.98e-05	0.00011	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CAV1—stomach cancer	1.96e-05	0.000109	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APOA1—stomach cancer	1.95e-05	0.000108	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6R—stomach cancer	1.95e-05	0.000108	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPP2R1A—stomach cancer	1.93e-05	0.000107	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TYMS—stomach cancer	1.91e-05	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—MAPK1—stomach cancer	1.91e-05	0.000106	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—EGFR—stomach cancer	1.91e-05	0.000106	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRKCB—stomach cancer	1.9e-05	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRKCB—stomach cancer	1.89e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTP1—stomach cancer	1.89e-05	0.000105	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6ST—stomach cancer	1.89e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—GSTM1—stomach cancer	1.89e-05	0.000105	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6ST—stomach cancer	1.88e-05	0.000105	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—HMOX1—stomach cancer	1.87e-05	0.000104	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	1.86e-05	0.000103	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	1.86e-05	0.000103	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—PIK3CA—stomach cancer	1.83e-05	0.000101	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SERPINE1—stomach cancer	1.82e-05	0.000101	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—APC—stomach cancer	1.82e-05	0.000101	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—APC—stomach cancer	1.81e-05	0.000101	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—KRAS—stomach cancer	1.8e-05	0.0001	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTT1—stomach cancer	1.78e-05	9.91e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—APC—stomach cancer	1.78e-05	9.9e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ERCC2—stomach cancer	1.78e-05	9.87e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.76e-05	9.79e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TYMS—stomach cancer	1.76e-05	9.77e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—RHOA—stomach cancer	1.76e-05	9.76e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—NOS3—stomach cancer	1.74e-05	9.66e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MAPK3—stomach cancer	1.74e-05	9.66e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—GSTM1—stomach cancer	1.74e-05	9.65e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MAPK3—stomach cancer	1.73e-05	9.63e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.72e-05	9.53e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	1.71e-05	9.48e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6R—stomach cancer	1.69e-05	9.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6R—stomach cancer	1.68e-05	9.34e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ENO1—stomach cancer	1.67e-05	9.28e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—MTHFR—stomach cancer	1.67e-05	9.28e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—PIK3CA—stomach cancer	1.66e-05	9.21e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—MAPK1—stomach cancer	1.66e-05	9.19e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6R—stomach cancer	1.66e-05	9.19e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—EGFR—stomach cancer	1.66e-05	9.19e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—MAPK1—stomach cancer	1.65e-05	9.16e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—EGFR—stomach cancer	1.65e-05	9.16e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ERCC2—stomach cancer	1.63e-05	9.08e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—ERBB2—stomach cancer	1.63e-05	9.04e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	1.62e-05	9.02e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	1.62e-05	9.02e-05	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—PIK3CA—stomach cancer	1.58e-05	8.78e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SERPINE1—stomach cancer	1.58e-05	8.77e-05	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—PIK3CA—stomach cancer	1.58e-05	8.76e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SERPINE1—stomach cancer	1.57e-05	8.74e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—KRAS—stomach cancer	1.56e-05	8.68e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—KRAS—stomach cancer	1.56e-05	8.65e-05	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.55e-05	8.62e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	1.55e-05	8.61e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CXCL8—stomach cancer	1.54e-05	8.57e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—CAV1—stomach cancer	1.54e-05	8.56e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—APOA1—stomach cancer	1.54e-05	8.54e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—MTHFR—stomach cancer	1.54e-05	8.53e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	1.53e-05	8.52e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—HRAS—stomach cancer	1.53e-05	8.52e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—RHOA—stomach cancer	1.52e-05	8.46e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—RHOA—stomach cancer	1.52e-05	8.43e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—NOS3—stomach cancer	1.51e-05	8.37e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN1B—stomach cancer	1.51e-05	8.37e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—NOS3—stomach cancer	1.5e-05	8.35e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—RHOA—stomach cancer	1.5e-05	8.3e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CD44—stomach cancer	1.48e-05	8.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—NOS3—stomach cancer	1.48e-05	8.22e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.47e-05	8.17e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—IL6—stomach cancer	1.47e-05	8.15e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CCND1—stomach cancer	1.44e-05	7.99e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—PIK3CA—stomach cancer	1.44e-05	7.98e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—JUN—stomach cancer	1.44e-05	7.97e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—PIK3CA—stomach cancer	1.43e-05	7.95e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—CAV1—stomach cancer	1.42e-05	7.87e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—APOA1—stomach cancer	1.41e-05	7.85e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—ERBB2—stomach cancer	1.41e-05	7.83e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	1.41e-05	7.83e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—ERBB2—stomach cancer	1.41e-05	7.81e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MMP9—stomach cancer	1.4e-05	7.75e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CDKN1A—stomach cancer	1.39e-05	7.73e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	1.38e-05	7.69e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK8—stomach cancer	1.36e-05	7.54e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PPARG—stomach cancer	1.35e-05	7.52e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CXCL8—stomach cancer	1.34e-05	7.43e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CXCL8—stomach cancer	1.33e-05	7.4e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—HRAS—stomach cancer	1.33e-05	7.38e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—HRAS—stomach cancer	1.32e-05	7.36e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	1.31e-05	7.29e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN1B—stomach cancer	1.31e-05	7.25e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	1.3e-05	7.24e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN1B—stomach cancer	1.3e-05	7.23e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	1.28e-05	7.12e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—IL6—stomach cancer	1.27e-05	7.06e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—IL6—stomach cancer	1.27e-05	7.04e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.26e-05	7e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VEGFA—stomach cancer	1.25e-05	6.96e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—IL6—stomach cancer	1.25e-05	6.93e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CCND1—stomach cancer	1.25e-05	6.92e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PPARG—stomach cancer	1.25e-05	6.92e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—JUN—stomach cancer	1.24e-05	6.91e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CCND1—stomach cancer	1.24e-05	6.9e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—STAT3—stomach cancer	1.24e-05	6.89e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—JUN—stomach cancer	1.24e-05	6.88e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTP1—stomach cancer	1.24e-05	6.87e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CCND1—stomach cancer	1.22e-05	6.79e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—JUN—stomach cancer	1.22e-05	6.78e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—HMOX1—stomach cancer	1.22e-05	6.77e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ALB—stomach cancer	1.22e-05	6.76e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MMP9—stomach cancer	1.21e-05	6.72e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MMP9—stomach cancer	1.21e-05	6.7e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CDKN1A—stomach cancer	1.21e-05	6.69e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CDKN1A—stomach cancer	1.2e-05	6.67e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MMP9—stomach cancer	1.19e-05	6.59e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK3—stomach cancer	1.19e-05	6.59e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	1.18e-05	6.57e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK8—stomach cancer	1.18e-05	6.53e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK8—stomach cancer	1.17e-05	6.51e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—NOS3—stomach cancer	1.16e-05	6.47e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	1.15e-05	6.41e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MYC—stomach cancer	1.15e-05	6.41e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TYMS—stomach cancer	1.15e-05	6.38e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—GSTM1—stomach cancer	1.14e-05	6.31e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—MAPK1—stomach cancer	1.13e-05	6.27e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—EGFR—stomach cancer	1.13e-05	6.27e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ALB—stomach cancer	1.12e-05	6.22e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VEGFA—stomach cancer	1.09e-05	6.03e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VEGFA—stomach cancer	1.08e-05	6.01e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—STAT3—stomach cancer	1.08e-05	5.97e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—STAT3—stomach cancer	1.07e-05	5.95e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—NOS3—stomach cancer	1.07e-05	5.95e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ERCC2—stomach cancer	1.07e-05	5.93e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	1.07e-05	5.92e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—KRAS—stomach cancer	1.07e-05	5.92e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PTGS2—stomach cancer	1.07e-05	5.92e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—STAT3—stomach cancer	1.06e-05	5.86e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK3—stomach cancer	1.03e-05	5.71e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK3—stomach cancer	1.02e-05	5.69e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	1.01e-05	5.6e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—MTHFR—stomach cancer	1e-05	5.58e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MYC—stomach cancer	1e-05	5.55e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MYC—stomach cancer	9.96e-06	5.53e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MYC—stomach cancer	9.81e-06	5.45e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PTGS2—stomach cancer	9.8e-06	5.44e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PIK3CA—stomach cancer	9.79e-06	5.44e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—MAPK1—stomach cancer	9.78e-06	5.43e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—EGFR—stomach cancer	9.78e-06	5.43e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—MAPK1—stomach cancer	9.75e-06	5.41e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—EGFR—stomach cancer	9.75e-06	5.41e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	9.6e-06	5.33e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—EGFR—stomach cancer	9.59e-06	5.33e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TP53—stomach cancer	9.47e-06	5.26e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—CAV1—stomach cancer	9.26e-06	5.14e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—APOA1—stomach cancer	9.24e-06	5.13e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—KRAS—stomach cancer	9.24e-06	5.13e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—KRAS—stomach cancer	9.21e-06	5.11e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—KRAS—stomach cancer	9.06e-06	5.03e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—HRAS—stomach cancer	9.06e-06	5.03e-05	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IL6—stomach cancer	8.67e-06	4.82e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PIK3CA—stomach cancer	8.49e-06	4.71e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PIK3CA—stomach cancer	8.46e-06	4.7e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	8.33e-06	4.62e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TP53—stomach cancer	8.21e-06	4.56e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TP53—stomach cancer	8.18e-06	4.54e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PPARG—stomach cancer	8.14e-06	4.52e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TP53—stomach cancer	8.06e-06	4.47e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—HRAS—stomach cancer	7.85e-06	4.36e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—HRAS—stomach cancer	7.83e-06	4.35e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—HRAS—stomach cancer	7.7e-06	4.28e-05	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IL6—stomach cancer	7.51e-06	4.17e-05	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IL6—stomach cancer	7.49e-06	4.16e-05	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IL6—stomach cancer	7.37e-06	4.09e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ALB—stomach cancer	7.32e-06	4.07e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—NOS3—stomach cancer	7.01e-06	3.89e-05	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3CA—stomach cancer	6.56e-06	3.64e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PTGS2—stomach cancer	6.41e-06	3.56e-05	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3CA—stomach cancer	6.03e-06	3.35e-05	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.94e-06	2.19e-05	CbGpPWpGaD
